Value Based Procurement on Target for June Launch, but Challenges Remain

Key Takeaways

• DHSC aims to launch VBP methodology in June 2024
• Workshops and training prepared for med‑tech suppliers and NHS officials
• Industry must provide evidence on outcomes, pathways, and sustainability
• NHS Supply Chain's engagement will shape VBP's effectiveness
• Clinician and community provider buy‑in critical for rollout success

Pulse Analysis

Value‑based procurement marks a strategic pivot for the NHS, moving away from pure cost‑competition toward rewarding demonstrable clinical benefit, patient experience improvements, and environmental stewardship. By quantifying outcomes and pathway efficiencies, VBP seeks to incentivize manufacturers to innovate in ways that directly address health system pressures. This aligns with broader UK policy goals of integrating care and reducing waste, positioning the NHS as a testbed for outcome‑driven spending that could influence other public sectors.

The rollout timeline is aggressive: key presentations at the Med‑Tech Expo on June 4 and the NHS Confederation event on June 10 will showcase the methodology, while a series of online and in‑person workshops aim to equip suppliers with the data‑submission skills they need. The supporting digital platform, Compass, is slated for a phased release, with a functional user version not expected until 2027, meaning early adopters must rely on manual processes. Critical challenges include the industry’s ability to produce robust real‑world evidence and the risk that NHS Supply Chain might default to price‑centric scoring, undermining the policy’s intent.

If successfully implemented, VBP could drive substantial cost efficiencies by prioritizing high‑value technologies and discouraging low‑impact, cheap alternatives. It also promises to accelerate the adoption of sustainable medical devices, as environmental impact becomes a scoring criterion. For clinicians, early involvement will be essential to define meaningful outcome metrics, while community providers must be brought into the conversation to ensure the approach scales beyond acute hospitals. Ultimately, VBP could become a template for value‑focused procurement worldwide, provided the NHS delivers the necessary cultural shift and transparent governance.